755
Views
12
CrossRef citations to date
0
Altmetric
Dermatology

Psoriasis treatment patterns: a retrospective claims study

, , , , &
Pages 1727-1733 | Received 22 Oct 2018, Accepted 10 May 2019, Published online: 17 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sydney Thai, Joe Zhuo, Yichen Zhong, Qian Xia, Xiu Chen, Ying Bao, Devender Dhanda, Lawshia Priya & Jashin J. Wu. (2023) Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies. Journal of Dermatological Treatment 34:1.
Read now
M Elaine Husni, Eunice Chang, Michael S Broder, Caleb Paydar, Katalin Bognar, Pooja Desai, Yuri Klyachkin & Ibrahim Khilfeh. (2022) Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database. Open Access Rheumatology: Research and Reviews 14, pages 123-132.
Read now

Articles from other publishers (10)

Ashis K. Das, Eunice Chang, Caleb Paydar, Michael S. Broder, Kate K. Orroth & Myriam Cordey. (2023) Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic. Dermatology and Therapy 13:9, pages 1973-1984.
Crossref
Sydney Thai, Sophie Barlow, James Lucas, James Piercy, Yichen Zhong, Joe Zhuo & Jashin J. Wu. (2023) Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey. Dermatology and Therapy 13:6, pages 1289-1303.
Crossref
April Armstrong, Qian Xia, Anand Rojer John, Vardhaman Patel & Lauren Seigel. (2022) Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis. Dermatology and Therapy 12:9, pages 2087-2103.
Crossref
David Kaplan, Elaine Husni, Eunice Chang, Michael S Broder, Caleb Paydar, Kata Bognar, Jessie Yan, Sven Richter, Pooja Desai & Ibrahim Khilfeh. (2022) Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use. Journal of Comparative Effectiveness Research 11:8, pages 575-582.
Crossref
Dominic Pilon, Timothy Fitzgerald, Maryia Zhdanava, Amanda Teeple, Laura Morrison, Aditi Shah & Patrick Lefebvre. (2022) Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA. Dermatology and Therapy 12:4, pages 971-987.
Crossref
Eugenia Piragine, Davide Petri, Alma Martelli, Agata Janowska, Valentina Dini, Marco Romanelli, Vincenzo Calderone & Ersilia Lucenteforte. (2022) Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis. Journal of Clinical Medicine 11:6, pages 1506.
Crossref
Raymond Milan, Jacques LeLorier, Marie-Josée Brouillette, Anne Holbrook, Ivan V. Litvinov & Elham Rahme. (2022) Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada. Frontiers in Pharmacology 13.
Crossref
Raymond Milan, Jacques LeLorier, Marie-Josée Brouillette, Anne Holbrook, Ivan V. Litvinov & Elham Rahme. (2021) Sex differences in factors associated with switch between systemic agents among individuals with psoriasis: A retrospective cohort study in Quebec, Canada. JAAD International 4, pages 79-83.
Crossref
Xenophon Theodoridis, Maria G. Grammatikopoulou, Eleni-Maria Stamouli, Persefoni Talimtzi, Eirini Pagkalidou, Efterpi Zafiriou, Anna-Bettina Haidich & Dimitrios P. Bogdanos. (2021) Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials. Nutrition 82, pages 111024.
Crossref
Lun-Fei Liu, Ji-Su Chen, Jun Gu, Jin-Hua Xu, Hong-Zhong Jin, Xiao-Wen Pang, Gang Wang, Chen Yu, Zhi-Qiang Song, Zai-Pei Guo, Wei Li, Wei Lai, Pan-Gen Cui, Min Chen, Hong Fang, Cheng-Zhi Lyu, Yu-Zhen Li, Qing Sun, Hong-Fu Xie, Xiao-Ming Liu, Xing-Hua Gao, Yu-Ling Shi, Nai-Qing Zhao, Wei Zhang & Min Zheng. (2019) Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial. Archives of Dermatological Research 312:6, pages 437-445.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.